Research
Search
Genes / Clones
Expression
Mutants / Tg
Antibodies
Anatomy / GO / Human Disease / Chemical
Publications
Data Mining
Downloads
Data Model
AllianceMine
BioMart
Genomics
BLAST
ZFIN
Ensembl
NCBI
UCSC
Genome Browsers
ZFIN
Ensembl
Vega
GRC
UCSC
NCBI
Resources
Zebrafish Genomics
Other Genome Databases
Resources
General
The Zebrafish Book
Protocol Wiki
Antibody Wiki
Anatomy Atlases
Resources for Students and Educators
Zebrafish Programs
ZF-Health
Husbandry Resources
More...
Resource Centers
Zebrafish International Resource Center (ZIRC)
China Zebrafish Resource Center (CZRC)
European Zebrafish Resource Center (EZRC)
Community
Announcements
News
Meetings
Jobs
Alliance Community Forum
Search
People
Labs
Companies
Societies
International Zebrafish Society (IZFS)
Zebrafish Disease Models Society (ZDMS)
Genetics Society of America (GSA)
Zebrafish Husbandry Association
Support
Nomenclature
Nomenclature Conventions
Line Designations
Wild-Type Lines
Submit a Proposed Gene Name
Submit a Proposed Mutant/Tg Line Name
Publications
Guidelines for Authors
Zebrashare
Citing ZFIN
Using ZFIN
Help & Tips
Glossary
Single Box Search Help
Submit Data
Terms of Use
About Us
About ZFIN
Contact Information
Statistics
Committees
Jobs at ZFIN
Sign In
Phenotype Summary
Fish:
la2Tg
Conditions:
All
Phenotypes
Publication
Data
Phenotype
Lin
et al.
, 2021
Fig. 2
blood thrombocyte normal amount, normal
head kidney hematopoietic multipotent progenitor cell normal amount, normal
head kidney hematopoietic stem cell normal amount, normal
head kidney lymphocyte normal amount, normal
head kidney monocyte normal amount, normal
head kidney nucleate erythrocyte normal amount, normal
head kidney thromboblast normal amount, normal
head kidney thrombocyte normal amount, normal
Fig. 3
caudal fin blood coagulation normal process quality, normal
caudal hematopoietic tissue blood coagulation normal process quality, normal
gill blood coagulation normal process quality, normal
Fig. 4
blood thromboblast normal amount, normal
blood thrombocyte normal amount, normal
caudal hematopoietic tissue thrombocyte normal amount, normal
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell normal amount, normal
ventral wall of dorsal aorta hematopoietic stem cell normal amount, normal
Fig. 5
caudal hematopoietic tissue apoptotic process normal process quality, normal
caudal hematopoietic tissue cell population proliferation normal process quality, normal
thromboblast cell population proliferation normal process quality, normal
thrombocyte cell population proliferation normal process quality, normal
Fig. 6
caudal hematopoietic tissue thrombocyte normal amount, normal
Fig. 7
caudal hematopoietic tissue thrombocyte increased amount, abnormal
caudal hematopoietic tissue thrombocyte normal amount, normal
Frame
et al.
, 2020
Fig. 1
caudal hematopoietic tissue hematopoietic multipotent progenitor cell increased amount, abnormal
Fig. 6
hematopoietic multipotent progenitor cell
il1b
expression increased amount, abnormal
Freire
et al.
, 2020
Fig. 5
posterior caudal vein blood coagulation, fibrin clot formation normal process quality, normal
posterior caudal vein platelet aggregation normal process quality, normal
Eneman
et al.
, 2017
Fig. 5
glomerular filtration process quality, abnormal
pericardium edematous, abnormal
whole organism
nphs1
expression decreased amount, abnormal
whole organism dead, abnormal
whole organism morphology, abnormal
Fig. 7
thrombocyte amount, normal
Fig. 8
pericardium edematous, abnormal
whole organism dead, abnormal
whole organism morphology, abnormal
Fig. S2
whole organism
adcyap1a
expression decreased amount, abnormal
Lin
et al.
, 2017
Fig. 3
thrombocyte decreased amount, abnormal
Fig. 4
hemostasis increased duration, abnormal
Oo
et al.
, 2017
Fig. 3
caudal hematopoietic tissue hematopoietic stem cell decreased amount, abnormal
Esain
et al.
, 2015
Fig. 2
intermediate cell mass of mesoderm hematopoietic stem cell decreased amount, abnormal
intermediate cell mass of mesoderm hematopoietic stem cell increased amount, abnormal
Fig. 5
intermediate cell mass of mesoderm hematopoietic stem cell increased amount, abnormal
Fig. 6
intermediate cell mass of mesoderm hematopoietic stem cell decreased amount, abnormal
intermediate cell mass of mesoderm hematopoietic stem cell increased amount, abnormal
Bielczyk-MaczyĆska
et al.
, 2014
Fig. 6
thrombocyte decreased amount, abnormal
Carroll
et al.
, 2014
Fig. 1
hematopoietic stem cell decreased amount, abnormal
Fig. 7
hematopoietic stem cell decreased amount, abnormal
hematopoietic stem cell increased amount, abnormal
Your Input Welcome
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Name:
Institution:
Email address:
Please leave blank:
Subject:
Comments:
Send your comments
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.